The University of Tennessee Health Science Center has landed $3.2 million in federal money to upgrade a laboratory used for research on infectious diseases. In a news release, the Memphis campus says the the National Institute of Allergy and Infectious Diseases awarded the money for equipment and infrastructure improvements at the Regional Biocontainment Laboratory.
RedHill Biopharma Ltd., a specialty biopharmaceutical company primarily focused on the development and commercialization of proprietary drugs for the treatment of gastrointestinal diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved Talicia® (omeprazole magnesium, amoxicillin and rifabutin) delayed-release capsules 10 mg1/250 mg/12.5 mg for the treatment of Helicobacter pylori (H. pylori)… Read More
Preliminary research suggesting that some diabetes patients may be injecting medicine that has partially disintegrated is causing concern even as serious questions are raised about the research itself… “If that were true, then you would have the emergency rooms full with uncontrolled diabetic patients,” said Bernd Meibohm, a pharmaceutical sciences professor and research director at… Read More
